dichlororibofuranosylbenzimidazole has been researched along with guanosine monophosphate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azoulay, E; Baud, L; Bellocq, A; Cadranel, J; Flahault, A; Fouqueray, B; Marullo, S; Philippe, C | 1 |
1 other study(ies) available for dichlororibofuranosylbenzimidazole and guanosine monophosphate
| Article | Year |
|---|---|
Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms.
Topics: Arginine; Atrial Natriuretic Factor; Cell Line; Cycloheximide; Dichlororibofuranosylbenzimidazole; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Free Radical Scavengers; Guanosine Monophosphate; Humans; Hydrogen Peroxide; NG-Nitroarginine Methyl Ester; Nitrogen; Protein Synthesis Inhibitors; Pulmonary Alveoli; Reactive Oxygen Species; RNA Processing, Post-Transcriptional; Superoxide Dismutase; Time Factors; Transcription, Genetic; Transforming Growth Factor beta; Xanthine Oxidase | 1999 |